Advertisement

 

 

Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies.

Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies.
Author Information (click to view)

Ahmed Y, Tian M, Gao Y,


Ahmed Y, Tian M, Gao Y, (click to view)

Ahmed Y, Tian M, Gao Y,

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

AIDS research and therapy 2017 09 1214(1) 50 doi 10.1186/s12981-017-0178-3

Abstract

The extreme HIV diversity posts a great challenge on development of an effective anti-HIV vaccine. To solve this problem, it is crucial to discover an appropriate immunogens and strategies that are able to prevent the transmission of the diverse viruses that are circulating in the world. Even though there have been a number of broadly neutralizing anti-HIV antibodies (bNAbs) been discovered in recent years, induction of such antibodies to date has only been observed in HIV-1 infection. Here, in this mini review, we review the progress in development of HIV vaccine in eliciting broad immune response, especially production of bNAbs, discuss possible strategies, such as polyvalent sequential vaccination, that facilitates B cell maturation leading to bNAb response.

Submit a Comment

Your email address will not be published. Required fields are marked *

four × 1 =

[ HIDE/SHOW ]